Market Research Industry Reports

Correvio Pharma Corp (COM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Correvio Pharma Corp(Correvio) formerly known as Cardiome Pharma Corp, is a specialty pharmaceutical company, which develops and commercializes therapies for the treatment and prevention of cardiovascular diseases. The companys product portfolio includes two marketed products: Brinavess, for the rapid conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults; and Aggrastat, a GP IIb/IIIa inhibitor used for the treatment of acute coronary syndrome (ACS). Correvio has collaborations with other pharmaceutical companies to commercialize its products. It has operational presence with offices located in Canada, the US, Switzerland and the UK. Correvio is headquartered in Vancouver, British Columbia, Canada.

Correvio Pharma Corp (COM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 5
List of Figures 5
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Correvio Pharma Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Correvio Pharma Corp, Medical Devices Deals, 2012 to YTD 2018 11
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deal Details 14
Partnerships 14
Evotec and Artesian Therapeutics Enter into Agreement 14
Cardiome Pharma Enters into Agreement with Chong Kun Dang for BRINAVESS 15
Cardiome Pharma Enters into Agreement with Mitsubishi Tanabe Pharma Europe 16
Cardiome Pharma Enters into Commercialization Agreement with AOP Orphan Pharma 17
Cardiome Pharma Enters into Agreement with Eddingpharm to Develop and Commercialize Brinavess 18
Cardiome Pharma Enters into Co-Marketing Agreement with Aspen Pharma for Brinavess 19
Correvio International Enters into Distribution Agreement with Eurolab Especialidades for Brinavess 20
Cardiome Pharma Enters into Commercialization Agreement with AOP Orphan Pharma for Aggrastat 21
Cardiome Pharma Enters Into Commercialization Agreement With UDG Healthcare For Brinavess In Ireland 22
Cardiome Enters Into Commercialization Agreement With Algorithm For Brinavess 23
Cardiome Pharma Enters Into Commercialization Agreement With Tzamal Medical For Brinavess 24
Cardiome Pharma Enters Into Commercialization Agreement With AOP Orphan Pharma For Brinavess 25
Cardiome Pharma Enters Into Co-Marketing Agreement With Merck For Brinavess 26
Licensing Agreements 27
ZAO Firma Enters into Licensing Agreement with Correvio 27
Correvio International Enters into Licensing Agreement with ATCO Laboratories 28
Cardiome Pharma Enters into Licensing Agreement with Basilea Pharma 29
Tzamal Medical Enters into Licensing Agreement with Cardiome Pharma 30
Cardiome Enters into Licensing Agreement with Allergan for XYDALBA 31
Eddingpharm Enters into Licensing Agreement with Correvio International 32
SteadyMed Enters into Licensing Agreement with Cardiome Pharma 33
Equity Offering 34
Correvio Pharma Plans to Raise up to USD250 Million in Public Offering of Securities 34
Cardiome Pharma Raises USD34.5 Million in Public Offering of Shares 35
Cardiome Pharma to Raise up to USD20 Million in Private Placement of Shares 37
Cardiome Pharma Raises USD23 Million in Public Offering of Shares 39
Cardiome Pharma Completes Public Offering Of Shares For Us$13.7 Million 41
Acquisition 43
Cipher Pharma Acquires Cardiome Pharma for USD19.5 Million 43
Cardiome Pharma Acquires Correvio, Cardiovascular Products Provider 45
CarCor Investment Acquires 16.6% Stake In Cardiome Pharma 46
Correvio Pharma Corp - Key Competitors 47
Correvio Pharma Corp - Key Employees 48
Correvio Pharma Corp - Locations And Subsidiaries 49
Head Office 49
Other Locations & Subsidiaries 49
Recent Developments 50
Financial Announcements 50
May 15, 2018: Correvio Announces First Quarter 2018 Financial Results 50
Mar 13, 2018: Cardiome Reports Fourth Quarter and Full Year 2017 Financial Results 52
Nov 14, 2017: Cardiome Reports Third Quarter 2017 Financial Results 54
Aug 08, 2017: Cardiome Reports Second Quarter 2017 Financial Results 56
May 15, 2017: Cardiome Reports First Quarter 2017 Financial Results 58
Mar 07, 2017: Cardiome Reports Fourth Quarter and Full Year 2016 Financial Results 59
Corporate Communications 61
May 16, 2017: Cardiome Reports Changes To Senior Management Team 61
Other Significant Developments 62
May 17, 2018: Correvio Pharma Formerly Cardiome Pharma, Announces Stock Ticker Symbol Change to CORV 62
May 10, 2018: Cardiome Announces Results From Annual and Special Meeting of Shareholders and Timing For First Quarter 2018 Financial Results Conference Call 63
Appendix 64
Methodology 64
About GlobalData 64
Contact Us 64
Disclaimer 64

List Of Tables


Correvio Pharma Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Correvio Pharma Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Correvio Pharma Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Correvio Pharma Corp, Medical Devices Deals, 2012 to YTD 2018 11
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Evotec and Artesian Therapeutics Enter into Agreement 14
Cardiome Pharma Enters into Agreement with Chong Kun Dang for BRINAVESS 15
Cardiome Pharma Enters into Agreement with Mitsubishi Tanabe Pharma Europe 16
Cardiome Pharma Enters into Commercialization Agreement with AOP Orphan Pharma 17
Cardiome Pharma Enters into Agreement with Eddingpharm to Develop and Commercialize Brinavess 18
Cardiome Pharma Enters into Co-Marketing Agreement with Aspen Pharma for Brinavess 19
Correvio International Enters into Distribution Agreement with Eurolab Especialidades for Brinavess 20
Cardiome Pharma Enters into Commercialization Agreement with AOP Orphan Pharma for Aggrastat 21
Cardiome Pharma Enters Into Commercialization Agreement With UDG Healthcare For Brinavess In Ireland 22
Cardiome Enters Into Commercialization Agreement With Algorithm For Brinavess 23
Cardiome Pharma Enters Into Commercialization Agreement With Tzamal Medical For Brinavess 24
Cardiome Pharma Enters Into Commercialization Agreement With AOP Orphan Pharma For Brinavess 25
Cardiome Pharma Enters Into Co-Marketing Agreement With Merck For Brinavess 26
ZAO Firma Enters into Licensing Agreement with Correvio 27
Correvio International Enters into Licensing Agreement with ATCO Laboratories 28
Cardiome Pharma Enters into Licensing Agreement with Basilea Pharma 29
Tzamal Medical Enters into Licensing Agreement with Cardiome Pharma 30
Cardiome Enters into Licensing Agreement with Allergan for XYDALBA 31
Eddingpharm Enters into Licensing Agreement with Correvio International 32
SteadyMed Enters into Licensing Agreement with Cardiome Pharma 33
Correvio Pharma Plans to Raise up to USD250 Million in Public Offering of Securities 34
Cardiome Pharma Raises USD34.5 Million in Public Offering of Shares 35
Cardiome Pharma to Raise up to USD20 Million in Private Placement of Shares 37
Cardiome Pharma Raises USD23 Million in Public Offering of Shares 39
Cardiome Pharma Completes Public Offering Of Shares For Us$13.7 Million 41
Cipher Pharma Acquires Cardiome Pharma for USD19.5 Million 43
Cardiome Pharma Acquires Correvio, Cardiovascular Products Provider 45
CarCor Investment Acquires 16.6% Stake In Cardiome Pharma 46
Correvio Pharma Corp, Key Competitors 47
Correvio Pharma Corp, Key Employees 48
Correvio Pharma Corp, Subsidiaries 49

List Of Figures


Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Correvio Pharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Correvio Pharma Corp, Medical Devices Deals, 2012 to YTD 2018 11

Correvio Pharma Corp (COM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Correvio Pharma Corp(Correvio) formerly known as Cardiome Pharma Corp, is a specialty pharmaceutical company, which develops and commercializes therapies for the treatment and prevention of cardiovascular diseases. The companys product

USD 250View Report

Mitsubishi Tanabe Pharma Corporation - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Mitsubishi Tanabe Pharma Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Mitsubishi Tanabe Pharma Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes

USD 350View Report

Zosano Pharma Corp (ZSAN) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Zosano Pharma Corp (Zosano Pharma), formerly ZP Holdings Inc is a biopharmaceutical company that develops proprietary transdermal delivery system. The company develops a transdermal microneedle patch system to deliver its

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Jul 2018
No. of Pages :64
Country :Canada
Category :Company Profiles
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube